Michelle Diane Kelsey
Assistant Professor of Medicine
Current Appointments & Affiliations
- Assistant Professor of Medicine, Medicine, Cardiology, Medicine 2022
Contact Information
- 200 Morris Street, Durham, NC 27701
- DUMC 3845, Durham, NC 27710
-
michelle.kelsey@duke.edu
(919) 668-8995
- Background
-
Education, Training, & Certifications
- Intern & Resident, Internal Medicine, Beth Israel Deaconess Medical Center 2015 - 2018
- M.D., University of Connecticut, School of Medicine 2015
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Kelsey, M. D., & Newby, L. K. (2022). In ASCVD, moderate-intensity statin + ezetimibe was noninferior to high-intensity statin alone at 3 y. Ann Intern Med, 175(11), JC126. https://doi.org/10.7326/J22-0085Full Text Link to Item
-
Rao, V. N., Mentz, R. J., Coniglio, A. C., Kelsey, M. D., Fudim, M., Fonarow, G. C., … Caughey, M. C. (2022). Neighborhood Socioeconomic Disadvantage and Hospitalized Heart Failure Outcomes in the American Heart Association Get With The Guidelines-Heart Failure Registry. Circ Heart Fail, 15(11), e009353. https://doi.org/10.1161/CIRCHEARTFAILURE.121.009353Full Text Link to Item
-
Grant, J. K., Snow, S., Kelsey, M., Rymer, J., Schaffer, A. E., Patel, M. R., … Shah, N. P. (2022). Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach. Curr Cardiol Rep, 24(10), 1373–1385. https://doi.org/10.1007/s11886-022-01751-zFull Text Link to Item
-
O’Toole, T., Kelsey, M. D., Shah, N. P., McGarrah, R. W., & Pagidipati, N. J. (2022). Eradicating Atherosclerosis: Should We Start Statins at Younger Ages and at Lower LDL-Cs. Curr Cardiol Rep, 24(10), 1397–1406. https://doi.org/10.1007/s11886-022-01760-yFull Text Link to Item
-
Drescher, C. S., Kelsey, M. D., Yankey, G. S., Sun, A. Y., Wang, A., Sadeghpour, A., … Kelsey, A. M. (2022). Imaging Considerations and Clinical Implications of Mitral Annular Disjunction. Circ Cardiovasc Imaging, 15(9), e014243. https://doi.org/10.1161/CIRCIMAGING.122.014243Full Text Link to Item
-
Kelsey, M. D., & Newby, L. K. (2022). Recommendations for use of ezetimibe and/or PCSK9 inhibitors in patients with elevated LDL-C. Ann Intern Med, 175(8), JC86. https://doi.org/10.7326/J22-0060Full Text Link to Item
-
Kelsey, M. D., Nelson, A. J., Green, J. B., Granger, C. B., Peterson, E. D., McGuire, D. K., & Pagidipati, N. J. (2022). Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison. J Am Coll Cardiol, 79(18), 1849–1857. https://doi.org/10.1016/j.jacc.2022.02.046Full Text Link to Item
-
Kelsey, M. D., Patrick-Lake, B., Abdulai, R., Broedl, U. C., Brown, A., Cohn, E., … Bloomfield, G. S. (2022). Inclusion and diversity in clinical trials: Actionable steps to drive lasting change. Contemp Clin Trials, 116, 106740. https://doi.org/10.1016/j.cct.2022.106740Full Text Link to Item
-
Kelsey, M. D., & Newby, L. K. (2022). In CV disease, GLP-1 RAs and SGLT2 inhibitors reduce CV mortality. Ann Intern Med, 175(3), JC26. https://doi.org/10.7326/J22-0003Full Text Link to Item
-
Nanna, M. G., Vemulapalli, S., Fordyce, C. B., Mark, D. B., Patel, M. R., Al-Khalidi, H. R., … Douglas, P. S. (2022). The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial. Am Heart J, 245, 136–148. https://doi.org/10.1016/j.ahj.2021.12.004Full Text Link to Item
-
Nelson, A. J., O’Brien, E. C., Kaltenbach, L. A., Green, J. B., Lopes, R. D., Morse, C. G., … Granger, C. B. (2022). Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease. Jama Netw Open, 5(2), e2148030. https://doi.org/10.1001/jamanetworkopen.2021.48030Full Text Link to Item
-
Rao, V. N., Kelsey, M. D., Blazing, M. A., Pagidipati, N. J., Fortin, T. A., & Fudim, M. (2022). Unexplained Dyspnea on Exertion: The Difference the Right Test Can Make. Circ Heart Fail, 15(2), e008982. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008982Full Text Link to Item
-
Kelsey, M., & Pagidipati, N. (2021). Towards a personalised approach for obesity treatment: one size does not fit all. Heart, 107(19), 1526–1527. https://doi.org/10.1136/heartjnl-2021-319726Full Text Link to Item
-
Kelsey, M., Page, C., Alhanti, B., Rhodes, S. L., Kent, S. T., Peterson, E., & Pagidipati, N. (2021). Lipoprotein(a) Testing Patterns in a Large Health System. Am J Cardiol, 153, 43–50. https://doi.org/10.1016/j.amjcard.2021.05.018Full Text Link to Item
-
Kelsey, M. D., & Granger, C. B. (2021). LOW-HARM score predicted mortality in patients hospitalized with COVID-19 in Mexico. Ann Intern Med, 174(5), JC59. https://doi.org/10.7326/ACPJ202105180-059Full Text Link to Item
-
Rao, V. N., Kelsey, M. D., Kelsey, A. M., Russell, S. D., Mentz, R. J., Patel, M. R., & Fudim, M. (2021). Acute cardiovascular hospitalizations and illness severity before and during the COVID-19 pandemic. Clin Cardiol, 44(5), 656–664. https://doi.org/10.1002/clc.23590Full Text Link to Item
-
Kelsey, M. D., & Newby, L. K. (2020). In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy. Ann Intern Med, 173(12), JC71. https://doi.org/10.7326/ACPJ202012150-071Full Text Link to Item
-
Kelsey, M. D., & Newby, L. K. (2020). In older patients with NSTE-ACS, clopidogrel safely reduced bleeding compared with ticagrelor at 1 year. Ann Intern Med, 173(6), JC28. https://doi.org/10.7326/ACPJ202009150-028Full Text Link to Item
-
Kelsey, M. D. (2015). Aporia in Medicine. Conn Med, 79(6), 365–366.Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.